Join
Live feed
·
INSIDERFilingvia Quantisnow
Travere Therapeutics Inc. logo

CHIEF MEDICAL OFFICER Inrig Jula exercised 24,250 shares at a strike of $18.47 and sold $1,015,086 worth of shares (22,485 units at $45.15) as part of a pre-agreed trading plan, increasing direct ownership by 2% to 113,238 units (SEC Form 4) (for tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TVTX (Travere Therapeutics Inc.) and more on Quantisnow.